Midbrain Neurotensin Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Midbrain neurotensin neurons are a population of neuromodulatory neurons located primarily in the ventral tegmental area (VTA) and substantia nigra pars compacta (SNc) that synthesize and release the neuropeptide neurotensin. These neurons play crucial roles in modulating dopaminergic signaling and have emerging significance in neurodegenerative disease research, particularly in Parkinson's disease. [1]
Neurotensin (NT) is a 13-amino acid neuropeptide originally discovered as a vasoactive peptide in the gut, but now recognized as an important neuromodulator in the central nervous system. In the midbrain, neurotensin neurons form a key component of the reward and motor control circuitry and interact extensively with dopaminergic systems. [2]
Midbrain neurotensin neurons are predominantly found in: [3]
Neurotensin acts through three G protein-coupled receptors: [4]
NTSR1 (NTR1): High-affinity receptor coupled to Gq/11 proteins
NTSR2 (NTR2): Low-affinity receptor
NTSR3 (NTR3/Sortilin): Non-G protein-coupled receptor
Neurotensin modulates dopamine neurons through: [5]
Neurotensin neurons have significant implications for PD:
Midbrain Neurotensin Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Midbrain Neurotensin Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Binder EB et al. Neurotensin. Psychopharmacology (Berl). 2001;159(1):42-56. 2001. ↩︎
Cáceda R et al. Neurotensin: role in psychiatric and neurological disorders. J Psychiatr Res. 2006;40(5):387-398. 2006. ↩︎
Watabe AM et al. Neurotensin as a factor promoting dopamine release. J Neurosci. 2000;20(8):2829-2835. 2000. ↩︎
St-Gelais F et al. Neurotensin increases dopamine release in the striatum. Neuropsychopharmacology. 2006;31(1):195-200. 2006. ↩︎
Richelson E et al. Neurotensin and its receptors. Handb Clin Neurol. 2023;196:137-153. 2023. ↩︎